Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19

SARS-CoV-2 has ushered a global pandemic with no effective drug being available at present. Although several FDA-approved drugs are currently under clinical trials for drug repositioning, there is an on-going global effort for new drug identification. In this paper, using multi-omics (interactome, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Barh, Debmalya, Tiwari, Sandeep, Weener, Marianna E., Azevedo, Vasco, Góes-Neto, Aristóteles, Gromiha, M. Michael, Ghosh, Preetam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547373/
https://www.ncbi.nlm.nih.gov/pubmed/33131530
http://dx.doi.org/10.1016/j.compbiomed.2020.104051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547373/
https://www.ncbi.nlm.nih.gov/pubmed/33131530
http://dx.doi.org/10.1016/j.compbiomed.2020.104051

Ejemplares similares